Allogeneic
[대역어] 동종
[용어속성] Term
[용어속성] Term
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Research
[키워드] 95% CI
95% confidence interval
age
Allogeneic
Analysis
autologous
Blood
C-reactive protein
cancer patient
Cell
Corticosteroid
COVID-19
COVID-19 in patient
COVID-19 mortality
CRP
defined
disease status
driven by
Factor
Hematological malignancies
Hematological malignancy
hospital
immune
Inflammation
laboratory-confirmed SARS-CoV-2 infection
large cohort
Logistic regression
low dose
lower mortality
multicenter
neutropenia
Older age
outcome
overall mortality
parameter
Patient
PCR assay
pediatric
performance status
recipient
Result
retrospective
severe COVID-19
Spain
Spanish
Stem cell transplantation
therapy
Treatment
[DOI] 10.1186/s40164-020-00177-z PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s40164-020-00177-z PMC 바로가기 [Article Type] Research
Harnessing Memory NK Cell to Protect Against COVID-19
Pharmacology
[키워드] adaptive
adaptive NK cell
addition
Against
Allogeneic
antiviral activity
approach
Cell
chemokine
chimeric antigen receptor
coronavirus disease
COVID-19
cytotoxicity
early stage
effective antiviral treatment
Evidence
exhibit
function
globe
HCMV
Human Cytomegalovirus
hyper inflammation
immune system
immunization
immunopathology
Immunotherapy
imperative
Infection
infections
Inflammatory cytokine
innate immune system
Interaction
lung tissue
memory
memory NK cell
MERS
natural
NK cell
NK cells
offer
pathogen-specific
Perspective
Prevalence
progression
Proinflammatory cytokine
protective role
public health crisis
residue
respiratory infection
Responder
responses
SARS-CoV-2
severe lung pathology
subset
suppresse
therapeutic potential
Treatment
vaccination
Vaccine
vaccine-induced immune response
viral infections
virus
viruses
[DOI] 10.3389/fphar.2020.01309 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.01309 PMC 바로가기 [Article Type] Pharmacology
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
Clinical Trial
[키워드] absolute neutrophil count
acute phase reactant
acute respiratory distress
administration
adverse event
Allogeneic
ARDS
average
bone
Bone marrow
C-reactive protein
CD3
CD4
CD8
clinical status
cohort study
COVID-19
criteria
Critically ill
Cytokine storm
D-dimer
declined
determine
downregulate
Efficacy
evaluated
Exosome
expired
ferritin
fraction
Future
Immunity
improvement
intravenous dose
Lymphocyte count
lymphopenia
Marrow
MSC
nonrandomized
Open-label
oxygen
Oxygenation
p value
PaO
Patient
polymerase chain
provided
Randomized controlled trial
RCTs
reduction
remained
safety endpoint
safety profile
SARS-CoV-2
severe COVID-19
single hospital
STEM
stem cell
survival rate
syndrome
therapeutic
therapeutic potential
Treatment
[DOI] 10.1089/scd.2020.0080 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1089/scd.2020.0080 PMC 바로가기 [Article Type] Clinical Trial
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
중증 COVID-19 환자를 치료하기 위한 동종 인간 치수 줄기세포의 안전성 및 효능 평가: 무작위 대조 시험(I/II상)을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acidic
Adenovirus
Admission
AIDS
Alanine
alanine aminotransferase
albumin
alkaline phosphatase
Allogeneic
allogeneic human dental pulp stem cells
amyloid
Analysis
anion gap
Arm ratio
aspartate
Aspartate aminotransferase
average
B lymphocyte
basophils
Before menopause
Bilirubin
blind
blinded
Block randomization method
Blood
blood cell
Blood cells
blood pressure
Blood routine
C-reactive protein
calcium
carbon dioxide
Care
CAST
caused
Cell
cell suspension
change
chest X-ray
Child Pugh score
chlorine
cholesterol
cholinesterase
CLARITY
clinical
Clinical improvement
clinical trial
coded
Coefficient of variation
color
commenced
comparator
computer
Concentration
Consent
consent form
Continuous renal replacement therapy
control group
control groups
COVID-19
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
COVID-2019
creatine
creatine kinase
creatinine
criteria
crystal
Cytokines
cytomegalovirus
cytomegalovirus CMV-IgG
cytomegalovirus CMV-IgM
Definition
dental pulp
dental pulp stem cells
description
detect
Diastolic blood pressure
direct bilirubin
discharge
disease
dissemination
distress
distribution
DPSCs
ECMO
Efficacy
element
enrolled
eosinophil
eosinophils
epithelial cells
estimated glomerular filtration rate
Estrogen
examined
excluded
exclusion criteria
experimental group
fat globules
Female patients
female subject
filtration rate
Final
flow cytometry
follow-up period
fungi
fungus
Globulin
glomerular filtration rate
Glucose
GRADE
Grade 1
grade 3
Grade 5
granulocyte
HBcAb
HBeAb
HBeAg
HBsAb
HBsAg
hDPSCs
Health Organization
heart rate
hematocrit
Hemodialysis
hemoglobin
hepatitis B
hepatitis C
HFNC
high density lipoprotein
hospitalised patient
Hospitalised patients
Hospitalization
Hospitalized
human DPSC
human DPSCs
hypersensitive C-reactive protein
hypoxia
Identifier
IgA
IgG
IgM
Il -10
IL-1
IL-1 β
IL-2
IL-4
IL-6
immune
Immunoglobulin
Immunological testing
improvement
IMV
inclusion criteria
Infectious disease
Influenza
Influenza virus
informed consent form
injection
Injections
intensive care
intensive care unit
Intravenous injection
Invasive mechanical ventilation
investigator
investigators
ITN-γ
ketone
ketone bodies
Kidney function
Kidney function tests
Killer cell
Laboratory
laboratory examinations
Lactate
lactate dehydrogenase
lactating women
leukocyte
leukocyte enzymes
lipoprotein
lipoprotein A
lipoprotein cholesterol
low density lipoprotein
lung lesion
lung lesions
lymphocyte
Lymphocytes
Macrophage
Magnesium
Medical care
Menopause
Monocytes
mononuclear cell
mononuclear cells
nasal
nasal catheter
natural killer
natural killer cell
neutrophil
Neutrophils
nitrite
NIV
Non-invasive
non-invasive mechanical ventilation
non-squamous epithelial cell
non-squamous epithelial cells
nucleic acid
nucleic acid test
number
objective
observation
occult
occult blood
Other
Other condition
outcome
oxygen
oxygen saturation
parallel group
parasites
partial pressure
participant
Patient
penetration
performed
Peripheral blood
Peritoneal dialysis
phase
phenotype
phosphatase
phosphorus
Placebo
placebo-controlled
Platelet
Platelet count
platelet distribution width
Platelets
Potassium
prealbumin
pregnancy test
pregnant
pressure
Primary outcome
Protein
protocol
random
randomisation
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
red blood cell
red blood cells
renal
renal insufficiency
renal replacement therapy
Renmin Hospital
replacement therapy
required
researcher
respiratory
respiratory distress
respiratory infection
respiratory rate
Safety
Saline
saline solution
Sample size
SARS-CoV-2
secondary
Secondary outcomes
serious COVID-19
serum
serum amyloid
severe liver condition
severe pneumonia
single-cell analyses
sodium
specific gravity
Standard deviation
status
stem cell
study period
Study protocol
sugar
syphilis
Systolic blood pressure
T lymphocyte
Th1 cytokine
Th1 cytokines
Th2 cytokine
Th2 cytokines
therapeutic effect
therapeutic effects
time
TNF-a
Total
total bilirubin
Total cholesterol
total protein
traits
Transferrin
treat
Treatment
treatment for COVID-19
triacylglycerol
Trial
triple blinded
TTCI
Tuberculosis
Twenty participant
Twenty participants
university
urea
uric acid
Urine
urobilinogen
Variation
Version
vital signs
Volume
website
White blood cells
with HIV
within 6 months
women
World Health Organization
Wuhan
γ-glutamyl transferase
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID ‐19
Concise Review
[키워드] accompanied
accumulated
acute respiratory distress
Allogeneic
ARDS
Asthma
Bacterial
bacterial pneumonia
chronic obstructive
clinical trial
Clinical use
COPD
COVID
COVID‐19
COVID‐19
curative
current
Cytokine storm
disease
Diseases
disorder
disorders
Effect
effective
Evidence
Gleaning
Idiopathic pulmonary fibrosis
immunomodulatory property
Influenza
lack
lung
lung disorders
mesenchymal stem cell
Mesenchymal stem cells
mortality rate
MSC
MSC therapy
MSCs
novel coronavirus disease
outcomes
pandemic
Perspective
preclinical data
pulmonary conditions
pulmonary disease
pulmonary injury
regenerative
reported
stem cell
Stem cell therapy
syndrome
therapeutic
therapeutic use
therapy
[DOI] 10.1002/sctm.20-0186 PMC 바로가기 [Article Type] Concise Review
[DOI] 10.1002/sctm.20-0186 PMC 바로가기 [Article Type] Concise Review
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection after allogeneic stem cell transplantation
Case Report
[키워드] acute respiratory syndrome
Allogeneic
allogeneic transplantation
characteristic
COVID‐19
COVID‐19
CT findings
hosts
Immunocompromised
Immunocompromised host
Infection
malignant lymphoma
Patient
SARS‐CoV‐2
Stem cell transplantation
[DOI] 10.1002/ccr3.2984 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1002/ccr3.2984 PMC 바로가기 [Article Type] Case Report
Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children
Research Article
[키워드] albumin
Allogeneic
Analysis
Autoimmune disease
calculated
cause
cell transplantation
children
clinician
Dexamethasone
Diagnosis
Disease progression
EBV
excluded
Factor
hazard ratio
HCT
hemoglobin
hemophagocytic lymphohistiocytosis
HLH
Hyperinflammatory syndrome
identify
immunodeficiency
Infection
malignancy
median age
medical record
outcome
parameter
Patient
patients
Pediatric patient
Platelet
Predictive
prognostic
Prognostic factor
Prognostic factor, risk stratification
regimen
Result
risk
secondary hemophagocytic lymphohistiocytosis
survival
survival analysis
Therapies
therapy
Treatment
Treatment response
virus
[DOI] 10.1186/s12887-020-02178-7 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12887-020-02178-7 PMC 바로가기 [Article Type] Research Article
Cell‐based therapy to reduce mortality from COVID ‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
Concise Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
adipose
Administered
adverse event
Allogeneic
alveolar
ARDS
Bone marrow
Cell therapy
clinical
clinical study
Combined
comparison
contribute
COVID
COVID‐19
COVID‐19 infection
COVID‐19
cytokine
cytokine production
death
determine
edema
Inflammatory
inflammatory biomarker levels
Injury
intravenously
literature review
Lung compliance
Macrophage
membrane
menstrual blood
Mesenchymal stromal cells
Mild
modulate
Mortality
MSC
MSC therapy
MSCs
nine
PaO
Participants
patients with ARDS
performed
Potential treatment
Pulmonary function
Radiographic
reduce mortality
reduction
remodeling processe
reported
resolved
Serious Adverse Event
shown
statistical significance
stromal cell
syndrome
systematic review
T‐cell
therapy
tissue
Trial
umbilical
variant
yielding
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
Reviews
[키워드] Administered
Allogeneic
biochemical
bortezomib
Cancer
Cell
clinical trial
Community
Comorbidities
Complication
Consensus
consensus paper
country
COVID-19
COVID-19 infection
COVID-19 pandemic
Dexamethasone
disease
drug interaction
early diagnosis
end organ damage
European
event
Hospital admission
hygiene
Immunocompromised
increased risk
infections
International
Local
Multiple myeloma
Myeloma
Nasopharyngeal swab
network
no symptom
Older age
oral
Patient
Patient education
PCR test
positive PCR test
provided
quarantine
regimen
risk
SARS-CoV-2
Severe COVID-19 Infection
social distancing measures
Spread
Surveillance
symptomatic COVID-19 disease
therapeutic decision
Treatment
[DOI] 10.1038/s41375-020-0876-z [Article Type] Reviews
[DOI] 10.1038/s41375-020-0876-z [Article Type] Reviews